Free Delivery on all orders over £39 *Exclusions Apply*

Product image

Regumate 0.22% Equine Oral Solution

£37.29£137.99

Legal category: POM-V
Read More

Upload Prescriptions

  • Prescription *

    Please upload your prescription for this product.Max file size: 25 MBPermitted file types: jpg jpeg jpe png gif pdf

Product total

Options total

Grand total

View POM

Delivery

All orders over £39 receive free delivery * *terms and conditions apply

Returns

Returns It should be noted that, unfortunately, we cannot accept returns of any labelled products, including prescription medicines and flea and worming products. If the customer has requested a cancellation but the order has already been dispatched then we will not be able to cancel and refund the order. This also applies if the customer has ordered the incorrect dosage. Returns of any labelled products are only acceptable if it is due to an error in processing, or for an official recall. We are also unable to accept the returns of Caninsulin syringes, even if the packaging is unopened.

View More

Description

Regumate Equine is used to control oestrus (“heat”) in mares. It is supplied as a liquid to be given directly into the mouth, or added to a small amount of food. It can be given daily to a mare early in her season and usually within 3 days it will stop that oestrus. Regumate can continue to be given once daily afterwards to prevent the return to oestrus. When daily dosing stops, 95% of mares will show signs of returning to oestrus within 5 days.

Regumate is usually used to prevent the hormone-dependant behavioural changes associated with oestrus, or to control the timing of ovulation so that the timing of mating and birth can be organised.

Please Note: A syringe is not included with these products. For a syringe to take the fluid out of the bottle please click here.

Regumate Equine 0.22% Oral Solution key features:

  • Suppression/prevention of oestrus (usually after 1 to 3 days of treatment) during prolonged periods of oestrus.
  • Control of the time of initiation of oestrus (approximately 90% of mares show signs of oestrus within 5 days following the end of treatment) and synchronisation of ovulation (60% of mares ovulate between days 11 and 14 following the end of treatment).

In order to ensure effective use of the product, the transitional status of mares showing some follicular activity should first be established.